Carbidopa Tablet
Product Images NDC 59651-146

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbidopa (NDC 59651-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Carbidopa Fig1)

This is a description of Carhidopa Tablets 25 mg, a medication used for the treatment of Parkinson's disease. Each tablet contains Carbidopa USP 25 mg and is intended for use with carbidopa-levodopa or with levodopa. The recommended adult dosage is specified in the accompanying circular. The tablets come in a bulk package and should be stored between 20°C to 25°C. This medication is distributed by Aurobindo Pharma USA, Inc. and is made in India. Keep out of reach of children. The barcode, coding area, and over-printing zone are also shown on the package.*

FDA Label Image

Chemical Structure (Carbidopa Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.